The “OSSICURE Bone Graft” is a cutting-edge bone substitute designed for lumbar spinal fusion surgeries. This innovation minimizes the need for using bone harvested from patients or donors, addressing cost limitations and reducing risks of complications. Developed in collaboration with medical experts and Thailand’s Food and Drug Administration (FDA), OSSICURE ensures safety and high standards for medical applications.
Thailand is transforming spinal treatment with this groundbreaking innovation, developed by the National Metal and Materials Technology Center (MTEC) under NSTDA, in partnership with the Faculty of Medicine at Siriraj Hospital, Mahidol University. A clinical trial agreement has been signed to evaluate the product’s safety and efficacy.
This advancement not only enhances access to effective treatments but also contributes to Thailand’s public health system and economic growth in the long term.
For more information : National Science and Technology Development Agency (NSTDA)
https://www.nstda.or.th/home/
EN
CN
DE
JP
TH
